Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sheng

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Biomaterials|July 24, 2015
Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytesYoung Wook Chun, Daniel A Balikov, Tromondae K Feaster, et al.
Cell Reports|December 24, 2016
Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and FibrosisJ Travis Hinson, Anant Chopra, Andre Lowe, et al.
The Lancet. Rheumatology|March 23, 2021
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trialPaul C Cremer, Antonio Abbate, Kristin Hudock, et al.
Science (New York, N.Y.)|August 29, 2015
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathyJohn T Hinson, Anant Chopra, Navid Nafissi, et al.
European Heart Journal Open|August 4, 2022
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammationPaul C Cremer, Calvin C Sheng, Debasis Sahoo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 22, 2025
[Expert consensus on combined screening for common cancers(2025 edition)]K X Chen, W Q Chen, Y B Huang, et al.
Circulation|March 27, 2023
Impaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated CardiomyopathyYoung Wook Chun, Matthew Miyamoto, Charles H Williams, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Biomaterials|July 24, 2015
Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytesYoung Wook Chun, Daniel A Balikov, Tromondae K Feaster, et al.
Cell Reports|December 24, 2016
Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and FibrosisJ Travis Hinson, Anant Chopra, Andre Lowe, et al.
The Lancet. Rheumatology|March 23, 2021
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trialPaul C Cremer, Antonio Abbate, Kristin Hudock, et al.
Science (New York, N.Y.)|August 29, 2015
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathyJohn T Hinson, Anant Chopra, Navid Nafissi, et al.
European Heart Journal Open|August 4, 2022
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammationPaul C Cremer, Calvin C Sheng, Debasis Sahoo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 22, 2025
[Expert consensus on combined screening for common cancers(2025 edition)]K X Chen, W Q Chen, Y B Huang, et al.
Circulation|March 27, 2023
Impaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated CardiomyopathyYoung Wook Chun, Matthew Miyamoto, Charles H Williams, et al.
Pageof 12